Skip to main content

Arvind Kush

Equibles does not estimate personal net worth.

Get an email with a short summary when Inhibikase Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IKT alerts

About Arvind Kush

Arvind Kush is recorded as Board Member at Inhibikase Therapeutics, Inc. (IKT). The newest filing on record that lists Arvind Kush as Board Member at Inhibikase Therapeutics, Inc. (IKT) is dated April 30, 2026. Inhibikase Therapeutics, Inc. reported in an 8-K filed October 22, 2024 that Arvind Kush was appointed Class III director of the Board, effective October 21, 2024. Inhibikase Therapeutics, Inc. reported in an 8-K filed October 10, 2024 that Arvind Kush was appointed director. Inhibikase Therapeutics, Inc. reported in an 8-K filed October 10, 2024 that Arvind Kush was appointed Class III director of the Board, effective October 21, 2024. Inhibikase Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inhibikase Therapeutics, Inc. includes Mark Iwicki (CEO and Board Member), Amit Munshi (Chairman and Board Member), Roberto Bellini (Chairman and Board Member) and 4 others.

“Arvind Kush to serve as a Class III director of the Board”
Inhibikase Therapeutics, Inc. Form 8-K, filed October 22, 2024 · Read the filing
“The Company's Board of Directors shall have increased the size of the Board of Directors by two (2) members (and not more than two (2) members) for a total size of seven (7) and shall have appointed Roberto Bellini, Amit Munshi, David Canner and Arvind Kush (each a "Closing Director") as directors to fill the four (4) vacancies created by such increase and the Resigning Directors (defined below), with the effectiveness of such appointments to occur no later than immediately prior to Closing.”
Inhibikase Therapeutics, Inc. Form 8-K, filed October 10, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Inhibikase Therapeutics, Inc.

Recent activity